Product
KIOVIG
1 clinical trial
1 indication
Indication
Primary Immunodeficiency DiseasesClinical trial
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects With Primary Immunodeficiency DiseasesStatus: Completed, Estimated PCD: 2021-01-15